Skip to main content
# Title Department Research Member Research Year
461 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2020
462 The diagnostic efficacy of tailored multiparametric breast MRI in indeterminate mammographic lesions: A single tertiary oncology center Department of Pathology Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2020
463 2. The reliability of the computed
tomography perfusion parameters as a
predictor of colorectal cancer grade:
influence of tumor region of interest
position
Department of Radiology Peter Edward megalaa sabaa 2020
464 Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? Department of Surgical Oncology Dr. Mahmoud Hussein Abdel-Azim Badawi 2020
465 Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? Department of Radiology Dr. Lamiaa Mohammed Refaat khalaf 2020
466 Long-Term Evaluation of Imatinib´s Effect on Bone Marrow Fibrosis in Patients with Chronic Myeloid Leukemia
Department of Clinical Pathology Prof. Hosny Badrawy Hamed Omran 2019
467 Circulating hematopoietic stem cells, endothelial
progenitor cells and cancer stem cells in
hepatocellular carcinoma patients: contribution to
diagnosis and prognosis
Department of Radiotherapy and Nuclear medicine Dr. Mona Mahmoud Sayed 2019
468 Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2019
469 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2019
470 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019